Drug Shortage Report for MINT-IRBESARTAN/HCTZ
| Report ID | 71060 |
| Drug Identification Number | 02393018 |
| Brand name | MINT-IRBESARTAN/HCTZ |
| Common or Proper name | Irbesartan- Hydrochlorothiazide |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE IRBESARTAN |
| Strength(s) | 12.5MG 300.0MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 count bottles |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2019-01-03 |
| Estimated end date | 2019-02-15 |
| Actual end date | 2019-01-14 |
| Shortage status | Resolved |
| Updated date | 2019-01-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2019-01-16 | English | Compare |
| v3 | 2019-01-04 | English | Compare |
| v2 | 2019-01-03 | French | Compare |
| v1 | 2019-01-03 | English | Compare |
Showing 1 to 4 of 4